Description
99% Purity Nutritional Supplements Mycophenolate Mofetil CAS 115007-34-6
Description
| Product Name: | Mycophenolate Mofetil | CAS: | 115007-34-6 |
|---|---|---|---|
| Molecular Formula: | C23H31NO7 | Molecular Weight: | 433.49 |
| Apperance: | White Powder | Purity: | 99% |
| MSDS: | Avaliable | MOQ: | 100gram |
| Package: | Foil Bag | ||
| High Light: |
Nutritional Supplements Mycophenolate Mofetil, CAS 115007-34-6 Nutritional Supplements, 99% Purity Mycophenolate Mofetil |
||
99% Purity nutritional health supplements Mycophenolate mofetil CAS 115007-34-6
| Product Name | Mycophenolate mofetil |
| CAS No. | 115007-34-6 |
| Molecular formula | C23H31NO7 |
| Molecular Weight | 433.49 |
| Grade Standard | Medicine Grade |
| Purity | 99%MIN |
| COA | Available |
Mainly used to prevent allogeneic organ rejection. Mainly kidney transplantation, but also suitable for heart and liver transplantation, especially refractory rejection after transplantation. It can be used simultaneously with cyclosporine and corticosteroids. It can also be applied to autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, primary glomerulonephritis, and psoriasis. Oral: Kidney transplantation: The initial dose is 2 to 3 mg/kg a day, and the maintenance dose is 1 to 2 mg/kg a day, divided into 2 to 3 times. Can be adjusted appropriately according to the condition. Rheumatoid arthritis: 300mg per day.
Clinical application
1. Organ transplantation is mainly used for kidney, liver and heart transplantation, which can significantly reduce the occurrence of acute rejection.
2. Autoimmune diseases are effective for psoriasis and rheumatoid arthritis, and have a certain effect on systemic lupus erythematosus vasculitis and severe IgA nephropathy.
3. Pneumocystis carinii Because MMF inhibits the activity of IMPDH required for the growth of Pneumocystis carinii, MMF can prevent Pneumocystis carinii infection.
